Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4451-4458

  Johnson, Michael E ^a,b   Murphy, Paul J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b BRISTOL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; HYALURONIC ACID; LACRYVISC; UNCLASSIFIED DRUG; VISMED;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRY EYE; EYE IRRITATION; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; OCULAR COMFORT INDEX; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RASCH ANALYSIS; SCORING SYSTEM; SELF CONCEPT; STATISTICAL SIGNIFICANCE; TEAR FLOW; TEST RETEST RELIABILITY; ADOLESCENT; ASTHENOPIA; MIDDLE AGED; PAIN; REPRODUCIBILITY; SICKNESS IMPACT PROFILE;

ADOLESCENT; ADULT; AGED; ASTHENOPIA; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 35748970482     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1253     Document Type: Article

References (40)

1. McMonnies CW. Key questions in a dry eye history. J Am Optom Assoc. 1986;57:512-517.
2. McMonnies C, Ho A, Wakefield D. Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol. 1998;438:835-838.
3. Nichols KK, Nichols JJ, Mitchell GL. The reliability and validity of McMonnies Dry Eye Index. Cornea. 2004;23:365-371.
4. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
5. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology. 2000;107:967-974.
6. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
7. Michell J. Quantitative science and the definition of measurement in Psychology. Br J Psychol. 1997;88:355-383.
8. Wright BD, Linacre JM. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil. 1989;70:857-860.
9. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall/CRC; 1999.
10. Krantz DH, Luce RD, Suppes P, Tversky A. Foundations of Measurement. Vol 1. New York: Academic Press; 1971.
11. Rasch G. Probabilistic Models for Some Intelligence and Attainment Tests. Copenhagen: Danmarks Paedagogiske Institut; 1960.
12. Massof RW. A systems model for low vision rehabilitation. II. Measurement of vision disabilities. Optom Vis Sci. 1998;75:349-373.
13. Massof RW. The measurement of vision disability. Optom Vis Sci. 2002;7:516-552.
14. Michell J. An Introduction to the Logic of Psychological Measurement. Hillsdale, NJ: Lawrence Erlbaum Associates; 1990.
15. Cox EP. The optimal number of response alternatives for a scale: a review. J Market Res. 1980;17:407-422.
16. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63:81-97.
17. Linacre JM. Optimizing rating scale category effectiveness. J Appl Meas. 2002;3:85-106.
18. Wright BD, Masters GN. Rating Scale Analysis: Rasch Measurement. Chicago: MESA Press; 1982.
19. Smith RM. The distributional properties of Rasch item fit statistics. Educ Psychol Measurement. 1991;51:541-565.
20. Smith RM, Schumacker RE, Bush MJ. Using item mean squares to evaluate fit to the Rasch model. J Outcome Meas. 1998;2:66-78.
21. Johnson ME, Murphy PJ. The effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements. Cornea. 2005;24:811-817.
22. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
23. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221-232.
24. Nichols KK, Smith JA. Association of clinical diagnostic tests and dry eye surveys: the NEI-VFQ-25 and the OSDI. Adv Exp Med Biol. 2002;506:1177-1181.
25. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44:4753-4761.
26. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol. 2005;243:531-538.
27. Linacre JM. WLNSTEPS Rasch Measurement Computer Program. Chicago: Winsteps.com; 2005.
28. Andrich D. A rating scale formulation for ordered response categories. Psychometrika. 1978;43:561-573.
29. Kline P. An Easy Guide to Factor Analysis. London: Routledge; 1994.
30. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
31. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-428.
32. Pesudovs K, Garamendi E, Keeves JP, Elliot DB. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci. 2003;44:2892-2899.
33. Wright BD, Linacre JM. Reasonable mean-square fit values. Rasch Meas Trans. 1994;8:370.
34. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610-618.
35. Toda I, Fujishima H, Tsubota K. Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh). 1993;71:347-352.
36. Nichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea. 2002;21:578-583.
37. Rimal RB, Real K. Assessing the perceived importance of skin cancer: how question-order effects are influenced by issue involvement. Health Educ Behav. 2005;32:398-342.
38. Wright BD. Estimating measures for extreme scores. Rasch Meas Trans. 1998;12:632-633.
39. Linacre JM. Estimating measures with known polytomous item difficulties. Rasch Measure Trans. 1998;12:638.
40. de Vet HC, Terwee CB, Ostelo RW, Beckerman H Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes. 2006;4:54.